EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER
The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3- morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MYNENI Praveen Chowdary YADLA Sheshu Babu GOGULA Venkata Ramana NANNAPANENI Venkaiah Chowdary |
description | The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3- morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof. The invention also relates to the treatment of head and neck cancer with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl- propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof, wherein the treating the head and neck cancer comprises reducing the size of one or more tumours associated with the head and neck cancer.
La invención se refiere al tratamiento del carcinoma de células escamosas recurrente y/o metastásico de cabeza y cuello (preferentemente carcinoma de células 5 escamosas recurrente de cabeza y cuello) con un compuesto que es (3-etinil-fenil)-[7- metoxi-6-(3-morfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del mismo. La invención también se refiere al tratamiento del cáncer de cabeza y cuello con un compuesto que es (3-etinil-fenil)-[7-metoxi-6-(3-m orfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del 10 mismo, en donde el tratamiento del cáncer de cabeza y cuello comprende reducir el tamaño de uno o más tumores asociados al cáncer de cabeza y cuello. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023014729A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023014729A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023014729A3</originalsourceid><addsrcrecordid>eNrjZLBwdXcLUvD08_B08gzxD1JwA-IQD1eFkCBXxxBfV78QBX83BQ9XRxcFRz8XBT9XZ28FZ0c_Z9cgHgbWtMSc4lReKM3NoOTmGuLsoZtakB-fWlyQmJyal1oS7xthZGBkbGBoYm5k6WhMlCIAbqMoVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER</title><source>esp@cenet</source><creator>MYNENI Praveen Chowdary ; YADLA Sheshu Babu ; GOGULA Venkata Ramana ; NANNAPANENI Venkaiah Chowdary</creator><creatorcontrib>MYNENI Praveen Chowdary ; YADLA Sheshu Babu ; GOGULA Venkata Ramana ; NANNAPANENI Venkaiah Chowdary</creatorcontrib><description>The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3- morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof. The invention also relates to the treatment of head and neck cancer with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl- propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof, wherein the treating the head and neck cancer comprises reducing the size of one or more tumours associated with the head and neck cancer.
La invención se refiere al tratamiento del carcinoma de células escamosas recurrente y/o metastásico de cabeza y cuello (preferentemente carcinoma de células 5 escamosas recurrente de cabeza y cuello) con un compuesto que es (3-etinil-fenil)-[7- metoxi-6-(3-morfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del mismo. La invención también se refiere al tratamiento del cáncer de cabeza y cuello con un compuesto que es (3-etinil-fenil)-[7-metoxi-6-(3-m orfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del 10 mismo, en donde el tratamiento del cáncer de cabeza y cuello comprende reducir el tamaño de uno o más tumores asociados al cáncer de cabeza y cuello.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240401&DB=EPODOC&CC=MX&NR=2023014729A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240401&DB=EPODOC&CC=MX&NR=2023014729A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MYNENI Praveen Chowdary</creatorcontrib><creatorcontrib>YADLA Sheshu Babu</creatorcontrib><creatorcontrib>GOGULA Venkata Ramana</creatorcontrib><creatorcontrib>NANNAPANENI Venkaiah Chowdary</creatorcontrib><title>EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER</title><description>The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3- morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof. The invention also relates to the treatment of head and neck cancer with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl- propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof, wherein the treating the head and neck cancer comprises reducing the size of one or more tumours associated with the head and neck cancer.
La invención se refiere al tratamiento del carcinoma de células escamosas recurrente y/o metastásico de cabeza y cuello (preferentemente carcinoma de células 5 escamosas recurrente de cabeza y cuello) con un compuesto que es (3-etinil-fenil)-[7- metoxi-6-(3-morfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del mismo. La invención también se refiere al tratamiento del cáncer de cabeza y cuello con un compuesto que es (3-etinil-fenil)-[7-metoxi-6-(3-m orfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del 10 mismo, en donde el tratamiento del cáncer de cabeza y cuello comprende reducir el tamaño de uno o más tumores asociados al cáncer de cabeza y cuello.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwdXcLUvD08_B08gzxD1JwA-IQD1eFkCBXxxBfV78QBX83BQ9XRxcFRz8XBT9XZ28FZ0c_Z9cgHgbWtMSc4lReKM3NoOTmGuLsoZtakB-fWlyQmJyal1oS7xthZGBkbGBoYm5k6WhMlCIAbqMoVA</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>MYNENI Praveen Chowdary</creator><creator>YADLA Sheshu Babu</creator><creator>GOGULA Venkata Ramana</creator><creator>NANNAPANENI Venkaiah Chowdary</creator><scope>EVB</scope></search><sort><creationdate>20240401</creationdate><title>EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER</title><author>MYNENI Praveen Chowdary ; YADLA Sheshu Babu ; GOGULA Venkata Ramana ; NANNAPANENI Venkaiah Chowdary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023014729A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MYNENI Praveen Chowdary</creatorcontrib><creatorcontrib>YADLA Sheshu Babu</creatorcontrib><creatorcontrib>GOGULA Venkata Ramana</creatorcontrib><creatorcontrib>NANNAPANENI Venkaiah Chowdary</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MYNENI Praveen Chowdary</au><au>YADLA Sheshu Babu</au><au>GOGULA Venkata Ramana</au><au>NANNAPANENI Venkaiah Chowdary</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER</title><date>2024-04-01</date><risdate>2024</risdate><abstract>The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3- morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof. The invention also relates to the treatment of head and neck cancer with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl- propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof, wherein the treating the head and neck cancer comprises reducing the size of one or more tumours associated with the head and neck cancer.
La invención se refiere al tratamiento del carcinoma de células escamosas recurrente y/o metastásico de cabeza y cuello (preferentemente carcinoma de células 5 escamosas recurrente de cabeza y cuello) con un compuesto que es (3-etinil-fenil)-[7- metoxi-6-(3-morfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del mismo. La invención también se refiere al tratamiento del cáncer de cabeza y cuello con un compuesto que es (3-etinil-fenil)-[7-metoxi-6-(3-m orfolin-4-il-propoxi)-quinazolin-4-il]-amina (NRC-2694) o una sal farmacéuticamente aceptable del 10 mismo, en donde el tratamiento del cáncer de cabeza y cuello comprende reducir el tamaño de uno o más tumores asociados al cáncer de cabeza y cuello.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2023014729A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A09%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MYNENI%20Praveen%20Chowdary&rft.date=2024-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023014729A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |